BioMarin Pharmaceutical Inc. buy Truist Financial Co.
Start price
05.09.24
/
50%
€81.14
Target price
05.09.25
€106.35
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 05.09.25. The prediction end date can be changed by Truist_Financial_Co_ at any time.Performance without dividends (%)
Name | 1w |
---|---|
BioMarin Pharmaceutical Inc. | - |
iShares Core DAX® | -1.215% |
iShares Nasdaq 100 | -1.911% |
iShares Nikkei 225® | -3.171% |
iShares S&P 500 | -1.029% |
Comments by Truist_Financial_Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Truist Financial Co. from $140.00 to $118.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€83.00
25.09.23
25.09.23
€131.92
25.09.24
25.09.24
-2.24%
04.09.24
04.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€82.68
15.09.23
15.09.23
€131.12
15.09.24
15.09.24
-1.86%
04.09.24
04.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.16
13.07.23
13.07.23
€125.20
13.07.24
13.07.24
3.31%
14.07.24
14.07.24